Dynamic Technology Lab Private LTD Provention Bio, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.65 - $7.3 $38,478 - $76,956	10,542 New	10,542 $42,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $94,669 - $219,410	-27,844 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $155,647 - $205,767	27,844 New	27,844 $156,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $85,754 - $126,207	-15,151 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.71 - $11.04 $64,778 - $106,580	-9,654 Reduced 38.92%	15,151 $128,000
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $251,026 - $482,457	24,805 New	24,805 $260,000
Q3 2020 Nov 13, 2020	SELL	$10.34 - $15.2 $248,832 - $365,788	-24,065 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $187,947 - $409,105	24,065 New	24,065 $340,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.